CHILDREN'S DIMETAPP NIGHTTIME COLD & CONGESTION OTC
Generic Name and Formulations:
Diphenhydramine HCl 6.25mg, phenylephrine HCl 2.5mg; per 5mL; syrup; grape-flavor; alcohol-free; contains sodium 4mg/5mL.
Pfizer Consumer Healthcare
Indications for CHILDREN'S DIMETAPP NIGHTTIME COLD & CONGESTION:
Nasal congestion, rhinorrhea, allergy symptoms.
20mL every 4 hours; max 6 doses/24 hours.
<6yrs: do not use. 6–11yrs: 10mL every 4 hours; max 6 doses/24 hours.
Children <6yrs old. During or within 14 days of MAOIs. Concomitant other diphenhydramine products (including topicals). For use as a sedative hypnotic.
Cardiovascular disease. Hypertension. Thyroid disease. Diabetes. GI or GU obstruction. Glaucoma. Asthma. Lower respiratory disorders. Pregnancy. Nursing mothers.
Antihistamine + sympathomimetic.
See Contraindications. Hypertensive crisis with MAOIs. β-blockers may increase pressor effects of sympathomimetics. Antihypertensives antagonized. Avoid alcohol. Increased CNS effects with other CNS depressants.
Drowsiness, anticholinergic effects, nervousness, dizziness, insomnia, excitability in children.
Syrup—4oz (w. dosing cup)
Endocrinology Advisor Articles
- Subclinical Hypothyroidism: Controversies in Testing and Treatment
- Canagliflozin Trial for T2D With CKD Stopped Early Due to Positive Results
- Favorable Outcomes With Second-Generation Insulin Analogs in Type 2 Diabetes
- Type 2 Diabetes and Alzheimer Disease: What's the Connection?
- Risk for Hypoglycemia During Titration With Insulin Glargine 100 U/mL in T2D
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Effect of SGLT2 Inhibitors on Heart Failure-Related Hospitalization, Below-Knee Amputation
- Nutraceuticals Containing Equol May Be Effective for Postmenopausal Symptoms
- Conservative Monitoring Strategy for Non-Functioning Pituitary Adenomas Evaluated
- FDA: Some Rx Drugs May Become Available Without Seeing a Doctor
- PM2.5 Contributes to Burden of Diabetes Mellitus Globally